The stock's rise snapped a four-day losing streak.
Vertex Pharmaceuticals (VRTX) stock in focus as company secures EU backing to expand label for its cystic fibrosis therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback